Profilo
Melissa Lozner is Chief Compliance Officer & Senior Vice President at Regeneron Pharmaceuticals, Inc. since 2022.
Former roles include Chief Compliance & Ethics Officer at Rafael Holdings, Inc. from 2021 to 2022, Attorney at Cravath, Swaine & Moore LLP, and Senior Legal Counsel at Novartis Oncology.
Education includes undergraduate studies at Cornell University and graduate studies at Boston University School of Law.
Posizioni attive di Melissa Lozner
| Società | Posizione | Inizio |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Responsabile della Conformità | 01/01/2022 |
Precedenti posizioni note di Melissa Lozner
| Società | Posizione | Fine |
|---|---|---|
| RAFAEL HOLDINGS, INC. | Responsabile della Conformità | 31/01/2022 |
Novartis Oncology | Consigliere Generale | - |
Cravath, Swaine & Moore LLP
Cravath, Swaine & Moore LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Formazione di Melissa Lozner
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Cravath, Swaine & Moore LLP
Cravath, Swaine & Moore LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Law
Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rafael Holdings, Inc.
Rafael Holdings, Inc. Real Estate DevelopmentFinance Operates as holding company with interest in real estate and pharmaceutical sector | Finance |
Novartis Oncology |
















